Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7860/JCDR/2017/24491.9359 http://scihub22266oqcxt.onion/10.7860/JCDR/2017/24491.9359 C5427330!5427330!28511404     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Diagn+Res 2017 ; 11 (3): FD01-2 Nephropedia Template TP {{tp|p=28511404|t=2017. Statin Induced Rhabdomyolysis with Non Oliguric Renal Failure: A Rare Presentation |pdf=|usr=}}{{28511404}} gab.com Text Statin Induced Rhabdomyolysis with Non Oliguric Renal Failure: A Rare Presentation JO: J Clin Diagn Res http://www.kidney.de/pget.php?&tw=1&pmid=28511404 #FOAvip Statins are safe, well tolerated, efficient and time tested drugs for the management of hypercholesterolemia, and thus play a cardinal role in the management of patients with heart disease. Although safe in clinical practice, they are associated with adverse effects, clinically the most important and most severe being muscle related complications/myotoxicity. Rhabdomyolysis, though rare, is the most severe form of myotoxicity. The US Food and Drug Administration (USFDA) adverse event reporting system reports rate of statin induced rhabdomyolysis at 0.3-13.5 cases per 1,000,000 patients. We present a case of a 74-year-old male who presented with an acute coronary syndrome and was initiated on atorvastatin. However, patient developed atorvastatin induced rhabdomyolysis, with non oliguric renal failure, which subsequently improved on cessation of medication. Twit Text FOAVip Statin Induced Rhabdomyolysis with Non Oliguric Renal Failure: A Rare Presentation ????J Clin Diagn Res http://www.kidney.de/pget.php?&tw=1&pmid=28511404 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28511404 #FOAvip English Wikipedia <ref>{{Cite pmid|28511404}}</ref> Statin Induced Rhabdomyolysis with Non Oliguric Renal Failure: A Rare Presentation #MMPMID28511404 Kareem H; Sahu D; Rao MS; Devasia T J Clin Diagn Res 2017[Mar]; 11 (3): FD01-2 PMID28511404show ga Statins are safe, well tolerated, efficient and time tested drugs for the management of hypercholesterolemia, and thus play a cardinal role in the management of patients with heart disease. Although safe in clinical practice, they are associated with adverse effects, clinically the most important and most severe being muscle related complications/myotoxicity. Rhabdomyolysis, though rare, is the most severe form of myotoxicity. The US Food and Drug Administration (USFDA) adverse event reporting system reports rate of statin induced rhabdomyolysis at 0.3-13.5 cases per 1,000,000 patients. We present a case of a 74-year-old male who presented with an acute coronary syndrome and was initiated on atorvastatin. However, patient developed atorvastatin induced rhabdomyolysis, with non oliguric renal failure, which subsequently improved on cessation of medication. äStatin Induced Rhabdomyolysis with Non Oliguric Renal Failure: A Rare (epmc).pdf DeepDyve Pubget Overpricing